Soleus Capital Management, L.P. Quant / Systematic

Location: Greenwich, CT

CIK: 0001802630 · Show all filings

Period: Q4 2019 (Next →)

Filing Date: Feb 14, 2020

Total Value: $104M (100.0% shares, 0.0% debt)

Holdings (49)

GRFS GRIFOLS S A 10.2%
Value $10.55M Shares 452,900 Est. Cost $23.29 Unrealized
ESSA PHARMA INC 8.7%
Value $8.989M Shares 1,634,369 Est. Cost $5.50 Unrealized
WRIGHT MED GROUP N V 6.7%
Value $6.909M Shares 226,700 Est. Cost $30.48 Unrealized
IVERIC BIO INC 5.5%
Value $5.734M Shares 668,371 Est. Cost $8.58 Unrealized
ALLERGAN PLC 5.3%
Value $5.448M Shares 28,500 Est. Cost $191.16 Unrealized
ADVERUM BIOTECHNOLOGIES INC 3.8%
Value $3.949M Shares 342,800 Est. Cost $11.52 Unrealized
DXCM DEXCOM INC 3.7%
Value $3.849M Shares 17,600 Est. Cost $47.43 Unrealized 0.0%
AEGLEA BIOTHERAPEUTICS INC 3.4%
Value $3.5M Shares 458,165 Est. Cost $7.64 Unrealized
ALEXION PHARMACEUTICALS INC 3.3%
Value $3.385M Shares 31,300 Est. Cost $108.15 Unrealized
MISONIX INC 3.2%
Value $3.323M Shares 178,596 Est. Cost $18.61 Unrealized
IRMD IRADIMED CORP 3.2%
Value $3.29M Shares 140,752 Est. Cost $21.36 Unrealized 0.0%
VCEL VERICEL CORP 3.1%
Value $3.196M Shares 183,680 Est. Cost $17.02 Unrealized 0.0%
EIGER BIOPHARMACEUTICALS INC 3.0%
Value $3.06M Shares 205,407 Est. Cost $14.90 Unrealized
ESTA ESTABLISHMENT LABS HLDGS INC 2.5%
Value $2.587M Shares 93,560 Est. Cost $22.15 Unrealized 0.0%
DERMIRA INC 2.4%
Value $2.495M Shares 164,600 Est. Cost $15.16 Unrealized
AXGN AXOGEN INC 2.2%
Value $2.28M Shares 127,450 Est. Cost $14.78 Unrealized 0.0%
BIIB BIOGEN INC 2.1%
Value $2.225M Shares 7,500 Est. Cost $277.46 Unrealized 0.0%
HUM HUMANA INC 2.0%
Value $2.125M Shares 5,800 Est. Cost $300.46 Unrealized 0.0%
XENE XENON PHARMACEUTICALS INC 2.0%
Value $2.118M Shares 161,600 Est. Cost $10.52 Unrealized 0.0%
BLUEPRINT MEDICINES CORP 2.0%
Value $2.114M Shares 26,400 Est. Cost $80.08 Unrealized
CONSTELLATION PHARMCETICLS I 1.9%
Value $1.983M Shares 42,100 Est. Cost $47.10 Unrealized
FOLD AMICUS THERAPEUTICS INC 1.8%
Value $1.838M Shares 188,800 Est. Cost $9.15 Unrealized 0.0%
HARPOON THERAPEUTICS INC 1.8%
Value $1.822M Shares 123,200 Est. Cost $14.79 Unrealized
KADMON HLDGS INC 1.5%
Value $1.586M Shares 350,300 Est. Cost $4.53 Unrealized
CRSP CRISPR THERAPEUTICS AG 1.3%
Value $1.358M Shares 22,300 Est. Cost $54.60 Unrealized 0.0%
STE STERIS PLC 1.3%
Value $1.341M Shares 8,800 Est. Cost $138.78 Unrealized 0.0%
STAA STAAR SURGICAL CO 1.2%
Value $1.264M Shares 35,940 Est. Cost $32.99 Unrealized 0.0%
ZYMEWORKS INC 1.0%
Value $1.031M Shares 22,700 Est. Cost $45.42 Unrealized
NEVRO CORP 0.9%
Value $969K Shares 8,246 Est. Cost $117.51 Unrealized
ZAFGEN INC 0.9%
Value $892K Shares 803,963 Est. Cost $1.11 Unrealized
ZEALAND PHARMA A S 0.9%
Value $892K Shares 26,882 Est. Cost $33.18 Unrealized
ICAD INC 0.7%
Value $737K Shares 94,900 Est. Cost $7.77 Unrealized
FLEXION THERAPEUTICS INC 0.7%
Value $722K Shares 34,900 Est. Cost $20.69 Unrealized
RFL RAFAEL HLDGS INC 0.7%
Value $676K Shares 37,925 Est. Cost $18.22 Unrealized 0.0%
INSP INSPIRE MED SYS INC 0.6%
Value $668K Shares 9,008 Est. Cost $64.28 Unrealized 0.0%
ARENA PHARMACEUTICALS INC 0.5%
Value $504K Shares 11,100 Est. Cost $45.41 Unrealized
TNDM TANDEM DIABETES CARE INC 0.4%
Value $453K Shares 7,600 Est. Cost $61.67 Unrealized 0.0%
NTRA NATERA INC 0.4%
Value $437K Shares 13,000 Est. Cost $36.86 Unrealized 0.0%
LIVONGO HEALTH INC 0.4%
Value $422K Shares 16,866 Est. Cost $25.02 Unrealized
ESPR ESPERION THERAPEUTICS INC NE 0.4%
Value $399K Shares 6,700 Est. Cost $44.96 Unrealized 0.0%
GH GUARDANT HEALTH INC 0.4%
Value $382K Shares 4,900 Est. Cost $72.06 Unrealized 0.0%
REVANCE THERAPEUTICS INC 0.4%
Value $376K Shares 23,200 Est. Cost $16.21 Unrealized
ARVN ARVINAS INC 0.3%
Value $357K Shares 8,700 Est. Cost $29.28 Unrealized 0.0%
PTCT PTC THERAPEUTICS INC 0.3%
Value $326K Shares 6,800 Est. Cost $42.49 Unrealized 0.0%
ARGX ARGENX SE 0.2%
Value $240K Shares 1,500 Est. Cost $160.00 Unrealized
SHOCKWAVE MED INC 0.2%
Value $237K Shares 5,400 Est. Cost $43.89 Unrealized
DICERNA PHARMACEUTICALS INC 0.2%
Value $235K Shares 10,700 Est. Cost $21.96 Unrealized
FATE FATE THERAPEUTICS INC 0.2%
Value $223K Shares 11,400 Est. Cost $15.88 Unrealized 0.0%
SNDX SYNDAX PHARMACEUTICALS INC 0.2%
Value $184K Shares 20,980 Est. Cost $7.34 Unrealized 0.0%